Donald Lloyd-Jones, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Lloyd-Jones’ research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. Other areas of interest include the use of novel biomarkers and imaging of subclinical atherosclerosis to improve prevention, and the epidemiology and outcomes of hypertension and dyslipidemia. His clinical and teaching interests lie in general cardiology, with a focus on prevention.

He also has been a national leader in public health and clinical approaches to promoting cardiovascular health and preventing cardiovascular diseases across the life course. He served as co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction; and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and the 2019 Primary Prevention Guidelines Panel. He has authored over 750 peer-reviewed scientific publications and has been a PI or co-investigator on more than 120 grants (the vast majority from NIH)

Publications

  • Published 9/19/2025

    Bowling CB, Sloane R, Faldowski RA, Pieper CF, Brown TH, Dooley EE, Burrows BT, Bhatt AS, Lloyd-Jones DM, Lewis CE, Pettee Gabriel K. Association of multimorbidity trajectories from early adulthood through middle age with middle-age physical function. J Gerontol A Biol Sci Med Sci. 2025 Sep 19; 80(10). PMID: 40580466.

    Read at: PubMed

  • Published 9/18/2025

    Aggarwal B, Gao Y, Alfini A, Azarbarzin A, Anafi RC, Glazer Baron K, Bautch VL, Bowles N, Broussard JL, Brown M, Cheng P, Cook SH, Cortese R, Fernandez FX, Galis Z, Johnson DA, Jelic S, Lipton JO, Lutsey PL, Miao Q, Ordovas JM, Prather AA, Swirski FK, Tasali E, Vargas I, Grandner MA, Lloyd-Jones D. Sleep and circadian rhythms in cardiovascular resilience: mechanisms, implications, and a Roadmap for research and interventions. Nat Rev Cardiol. 2025 Sep 18. PMID: 40968347.

    Read at: PubMed

  • Published 9/2/2025

    Wang Z, Taylor KD, Rotter JI, Rich SS, Zheng Y, Hou L, Guo X, Bressler J, Raffield LM, Liu Y, Kaplan R, Lloyd-Jones DM, Morrison AC, Fornage M, Sofer T. Estimating population structure using epigenome-wide methylation data. medRxiv. 2025 Sep 02. PMID: 40950500.

    Read at: PubMed

  • Published 9/1/2025

    Cameron NA, Petito LC, Colangelo LA, Gunderson EP, Catov JM, Grobman WA, Rana JS, Terry JG, Lloyd-Jones DM, Allen NB, Khan SS. Prepregnancy Cardiovascular Health, Gestational Diabetes, and Coronary Artery Calcium. JAMA Cardiol. 2025 Sep 01; 10(9):888-895. PMID: 40560557.

    Read at: PubMed

  • Published 9/1/2025

    Krishnan V, Huang X, Perak AM, Coresh J, Ndumele CE, Greenland P, Lloyd-Jones DM, Khan SS. PREVENT Risk Age Equations and Population Distribution in US Adults. JAMA Cardiol. 2025 Sep 01; 10(9):962-964. PMID: 40737004.

    Read at: PubMed

Other Positions

  • Director of Framingham Center for Population and Prevention Science, Framingham Heart Study
    Boston University
  • Principal Investigator of the Framingham Heart Study, Framingham Heart Study
    Boston University
  • Chief of the section, Preventive Medicine
    Boston University

Education

  • Columbia University College of Physicians and Surgeons, MD
  • Harvard School of Public Health, MS
  • Swarthmore College, BA